UTERINE LEIOMYOSARCOMA
Clinical trials for UTERINE LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UTERINE LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for UTERINE LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a breast cancer drug stall rare uterine cancer?
Disease control Recruiting nowThis study tests whether the drug letrozole can help keep uterine leiomyosarcoma from growing back after initial treatment. About 40 women with early-stage disease will take letrozole daily or be observed. The goal is to see if letrozole extends the time before the cancer progres…
Matched conditions: UTERINE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: GOG Foundation • Aim: Disease control
Last updated May 26, 2026 08:52 UTC
-
New drug shows promise for Hard-to-Treat uterine sarcomas
Disease control Recruiting nowThis study tests a drug called elacestrant in people with advanced uterine sarcomas that have estrogen receptors. The drug works by blocking estrogen, which may help shrink or slow the cancer. About 30 adults with certain types of uterine sarcoma will take the drug to see if it i…
Matched conditions: UTERINE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 08:39 UTC
-
Can chemo after surgery stop uterine cancer's return? new trial aims to find out.
Disease control Recruiting nowThis study tests whether giving standard chemotherapy (doxorubicin and trabectedin) after surgery can help people with uterine leiomyosarcoma stay cancer-free longer. It includes 48 adults whose tumors were fully removed but who have a high risk of relapse. The goal is to see if …
Matched conditions: UTERINE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC